ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
-0.15%
Bitcoin
67,725.44
0.36%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pulse Biosciences Inc (PLSE)

  7. Pulse Biosciences Inc (PLSE) News

PLSE

Pulse Biosciences (PLSE)

Pulse Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLSE
DateTimeSourceHeadlineSymbolCompany
01/06/202406:18Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:PLSEPulse Biosciences Inc
29/05/202407:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PLSEPulse Biosciences Inc
23/05/202404:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
23/05/202404:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
21/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
21/05/202406:05Business WirePulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
16/05/202422:00Business WirePulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingNASDAQ:PLSEPulse Biosciences Inc
15/05/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
15/05/202406:05Business WirePulse Biosciences Enhances Executive Leadership TeamNASDAQ:PLSEPulse Biosciences Inc
09/05/202423:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
09/05/202422:00Business WirePulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
08/05/202406:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLSEPulse Biosciences Inc
08/05/202406:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
08/05/202406:05Business WirePulse Biosciences Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
02/05/202422:00Business WirePulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
25/04/202406:05Business WirePulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024NASDAQ:PLSEPulse Biosciences Inc
29/03/202407:12Business WirePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
29/03/202407:10Business WirePulse Biosciences Announces Plans to Initiate a Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
15/03/202407:05Business WirePulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024NASDAQ:PLSEPulse Biosciences Inc
12/03/202400:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
09/03/202405:17Business WirePulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
15/02/202401:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
15/02/202400:00Business WirePulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility StudyNASDAQ:PLSEPulse Biosciences Inc
01/02/202400:00Business WirePulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF SymposiumNASDAQ:PLSEPulse Biosciences Inc
10/01/202401:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
03/01/202401:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
03/01/202400:00Business WirePulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac ClampNASDAQ:PLSEPulse Biosciences Inc
23/12/202301:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
21/12/202301:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
21/12/202300:00Business WirePulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac CatheterNASDAQ:PLSEPulse Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:PLSE

Your Recent History

TSXV
VCU
Vizsla Copper
EU
BE0002429042
Eandis Cvba EANDIS3.5%28...
BIT
UI694B
Bnp Paribas Issuance
EU
1108T
1108T
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved